DRUGS AND MEDICINE

340B Drug Pricing Program, reports, Minn. Law 2024 c 127 art 59 s 2, 57

Antibiotics, Minnesota One Health Antimicrobial Stewardship Collaborative, Minn. Law 2023 c 70 art 4 s 14, 2023 c 70 art 20 s 3

Authority to prescribe, dispense, and administer

Midwives, Minn. Law 2024 c 77 s 2

Opiate antagonists, school personnel, Minn. Law 2023 c 55 art 1 s 2

School personnel, Minn. Law 2023 c 61 art 5 s 1, 2024 c 109 art 8 s 5 to 2024 c 109 art 8 s 7

Cannabinoid products

Registration, Minn. Law 2024 c 121 art 2 s 9

Sales, testing, labeling, Minn. Law 2024 c 121 art 2 s 6 to 2024 c 121 art 2 s 8, 10, 11

Cannabinoid products, sales, testing, labeling, Minn. Law 2023 c 63 art 7 s 2

Containers, cannabinoid products, Minn. Law 2023 c 63 art 7 s 2

Controlled substances, see CONTROLLED SUBSTANCES

Definitions

Generic and off-patent drug excessive pricing prohibition, Minn. Law 2023 c 57 art 2 s 22

Prescription Drug Affordability Act, Minn. Law 2023 c 57 art 2 s 29

Prescription Drug Price Transparency Act, Minn. Law 2023 c 70 art 2 s 8

Drug abuse and dependency, see CHEMICALLY DEPENDENT PERSONS

Drug Formulary Committee, Minn. Law 2023 c 70 art 1 s 13

Epinephrine, auto-injectors, school personnel authorized to administer, Minn. Law 2024 c 109 art 8 s 7

Epinephrine, cost-sharing limits, Minn. Law 2023 c 57 art 2 s 46

Expired medication, temporary requirements, Minn. Law 2022 c 98 art 3 s 23

Formularies, medical assistance, Minn. Law 2023 c 70 art 1 s 15, 16

Generic drugs, excessive price increases prohibited, Minn. Law 2023 c 57 art 2 s 23

HIV prevention drugs, Minn. Law 2024 c 127 art 60 s 11

Insulin

Cost-sharing limits, health plan companies, Minn. Law 2023 c 57 art 2 s 46

Insulin manufacturers, registration fees, Minn. Law 2024 c 127 art 56 s 6

Insulin safety net program, Minn. Law 2023 c 70 art 6 s 28, 29, 2023 c 70 art 20 s 9

Safety net program, Minn. Law 2024 c 127 art 56 s 7, 8

Investigational drugs, medical assistance coverage, exclusion, Minn. Law 2022 c 98 art 2 s 9

Labels and labeling

Accessible labels

Assessment, Minn. Law 2024 c 127 art 60 s 24

Notice to consumer, Minn. Law 2024 c 127 art 60 s 10

Plain language, Minn. Law 2024 c 127 art 60 s 25

Cannabinoid products, Minn. Law 2024 c 121 art 2 s 8

Labels and labeling, cannabinoid products, Minn. Law 2023 c 63 art 7 s 2

Legend drugs

Dispensing, Minn. Law 2023 c 68 art 4 s 13

Emergency use, Minn. Law 2023 c 68 art 4 s 13

Legend drugs, dispensing, Minn. Law 2024 c 77 s 2

Manufacturers

340B Drug Pricing Program, prohibited activity, Minn. Law 2024 c 121 art 4 s 3

Cannabinoid products, testing, Minn. Law 2023 c 63 art 7 s 2

Disciplinary action, grounds for, Minn. Law 2023 c 57 art 2 s 60

Fees, Minn. Law 2023 c 70 art 6 s 22, 24

Generic and off-patent drugs

Drug cost statements, requirements, orders, Minn. Law 2023 c 57 art 2 s 25

Price increases, excessive, prohibited, Minn. Law 2023 c 57 art 2 s 23

Registered agents and offices, Minn. Law 2023 c 57 art 2 s 24

Severability of law, Minn. Law 2023 c 57 art 2 s 27

Withdrawal from sale or distribution prohibited, notice, penalties, Minn. Law 2023 c 57 art 2 s 26

Insulin manufacturers, registration fees, Minn. Law 2024 c 127 art 56 s 6

Medication repository program, Minn. Law 2023 c 70 art 6 s 27

Prescription Drug Affordability Advisory Council, representation, Minn. Law 2023 c 57 art 2 s 31

Purchasing agreements, Human Services Department, Minn. Law 2023 c 70 art 1 s 17

Reimbursement, insulin safety net program, Minn. Law 2024 c 127 art 56 s 4 to 2024 c 127 art 56 s 6

Reports given, Minn. Law 2023 c 70 art 2 s 16

Manufacturers, cannabinoid products, testing, Minn. Law 2022 c 98 art 13 s 6 to 2022 c 98 art 13 s 9

Medical gases, see MEDICAL GASES

Medical marijuana, see MEDICAL CANNABIS

Misbranding, Minn. Law 2023 c 63 art 7 s 2

Off-patent drugs, Excessive price increases prohibited, Minn. Law 2023 c 57 art 2 s 23

Opioids and opiates, see under CONTROLLED SUBSTANCES

Packages and packaging, cannabinoid products, Minn. Law 2023 c 63 art 7 s 2, 2024 c 121 art 2 s 8

Prescription Drug Price Transparency Act, Minn. Law 2023 c 70 art 2 s 8 to 2023 c 70 art 2 s 21, 43

Prescription drugs

340B Drug Pricing Program

Access to drugs, Minn. Law 2024 c 121 art 4 s 3

Reports, Minn. Law 2024 c 127 art 59 s 2, 57

Asthma inhalers, cost-sharing limits, health plan companies, Minn. Law 2023 c 57 art 2 s 46

Clinician-administered drugs, safety and care requirements, Minn. Law 2023 c 57 art 2 s 54

Cost containment, 340B Drug Pricing Program, Minn. Law 2024 c 127 art 59 s 2

Epinephrine auto-inhalers, cost-sharing limits, health plan companies, Minn. Law 2023 c 57 art 2 s 46

Insulin, cost-sharing limits, health plan companies, Minn. Law 2023 c 57 art 2 s 46

Medical assistance, Minn. Law 2024 c 127 art 54 s 6, 7, 2024 c 127 art 55 s 9

Medicare Part D prescription drug coverage, Prescription Drug Affordability Board decisions, exemption, Minn. Law 2023 c 57 art 2 s 37

Medication repository program, Minn. Law 2023 c 70 art 6 s 27, 2024 c 127 art 60 s 13 to 2024 c 127 art 60 s 20

Prescription Drug Affordability Act, Minn. Law 2023 c 57 art 2 s 28 to 2023 c 57 art 2 s 38

Prescription drugs of substantial public interest reporting, Minn. Law 2024 c 127 art 59 s 4

Prescriptions written by nonphysicians, revisor's correction, Minn. Law 2023 c 25 s 5

Prices, Minn. Law 2023 c 57 art 2 s 23

Prescription drugs, health plan coverage, Minn. Law 2022 c 44 s 4

Prices

Excessive price increases prohibited, generic drugs, Minn. Law 2023 c 57 art 2 s 23

Prescription Drug Affordability Act, Minn. Law 2023 c 57 art 2 s 28 to 2023 c 57 art 2 s 38

Prices, 340B Drug Pricing Program, Minn. Law 2024 c 127 art 59 s 2, 57

Psychedelic medicine task force, Minn. Law 2023 c 70 art 4 s 99, 2023 c 70 art 20 s 3

Sales and use taxes, Minn. Law 2023 c 63 art 2 s 13

Wholesale dealers, licenses, fees, Minn. Law 2023 c 70 art 6 s 22, 24

Wholesale drug distributors

Generic drug price increase prohibition, exemption, Minn. Law 2023 c 57 art 2 s 23

Medication repository program, Minn. Law 2023 c 70 art 6 s 27

Prescription Drug Affordability Advisory Council, representation, Minn. Law 2023 c 57 art 2 s 31

Reports given, substantial public interest, Minn. Law 2023 c 70 art 2 s 19